Published in Front Pharmacol on June 07, 2016
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics (2004) 32.08
WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics (2008) 18.58
NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res (2008) 17.35
UniProt: a hub for protein information. Nucleic Acids Res (2014) 16.72
limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res (2015) 14.81
In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol (2002) 11.62
Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett (2004) 11.00
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2013) 8.29
Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 7.02
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell (2005) 4.46
A framework for oligonucleotide microarray preprocessing. Bioinformatics (2010) 3.97
Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet (2007) 2.55
Zebrafish pigmentation mutations and the processes of neural crest development. Development (1996) 2.14
Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol (2009) 1.79
Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration (2007) 1.67
Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. Genome Biol (2015) 1.64
Mast cells promote lung vascular remodelling in pulmonary hypertension. Eur Respir J (2010) 1.57
Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol (2010) 1.48
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects. Hum Mutat (2015) 1.38
TGFβ signaling and cardiovascular diseases. Int J Biol Sci (2012) 1.35
The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol (2010) 1.33
Transcriptome-based systematic identification of extracellular matrix proteins. Proc Natl Acad Sci U S A (2008) 1.31
Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.29
Management of pulmonary arterial hypertension. J Am Coll Cardiol (2015) 1.29
CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish. Methods (2014) 1.28
Anterior gradient 2: a novel player in tumor cell biology. Cancer Lett (2011) 1.16
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics (2008) 1.14
Metabolomic heterogeneity of pulmonary arterial hypertension. PLoS One (2014) 1.07
Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun (2013) 1.06
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res Cardiol (2012) 1.06
Aquaculture and husbandry at the zebrafish international resource center. Methods Cell Biol (2011) 1.04
BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH. Hum Mol Genet (2012) 1.01
Granzymes in age-related cardiovascular and pulmonary diseases. Cell Death Differ (2010) 0.98
Zebrafish as a systems toxicology model for developmental neurotoxicity testing. Congenit Anom (Kyoto) (2015) 0.93
New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication. Chest (2015) 0.93
Efficient Multiple Genome Modifications Induced by the crRNAs, tracrRNA and Cas9 Protein Complex in Zebrafish. PLoS One (2015) 0.93
Co-expression of FBN1 with mesenchyme-specific genes in mouse cell lines: implications for phenotypic variability in Marfan syndrome. Eur J Hum Genet (2010) 0.93
Protective role of IL-6 in vascular remodeling in Schistosoma pulmonary hypertension. Am J Respir Cell Mol Biol (2013) 0.90
Novel and emerging therapies for pulmonary hypertension. Am J Respir Crit Care Med (2014) 0.89
Circulating Proteomic Signatures of Chronological Age. J Gerontol A Biol Sci Med Sci (2014) 0.88
Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosis. Chest (2011) 0.88
Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype. Prostate (2012) 0.87
Using zebrafish in systems toxicology for developmental toxicity testing. Congenit Anom (Kyoto) (2016) 0.85
Inhibitory SMADs: potential regulators of ovarian function. Biol Reprod (2014) 0.84
Stress-induced ECM alteration modulates cellular microRNAs that feedback to readjust the extracellular environment and cell behavior. Front Genet (2013) 0.84
New developments on gill innervation: insights from a model vertebrate. J Exp Biol (2008) 0.84
De novo synthesize of bile acids in pulmonary arterial hypertension lung. Metabolomics (2014) 0.84
Epigenetic regulation of insulin-like growth factor signaling: A novel insight into the pathophysiology of neonatal pulmonary hypertension. Vascul Pharmacol (2015) 0.83
Elevated pulmonary arterial pressure and altered expression of Ddah1 and Arg1 in mice lacking cavin-1/PTRF. Physiol Rep (2013) 0.82
Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension. J Pathol (2014) 0.82
Macitentan reverses early obstructive pulmonary vasculopathy in rats: early intervention in overcoming the survivin-mediated resistance to apoptosis. Am J Physiol Lung Cell Mol Physiol (2014) 0.81
Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease. Am J Respir Cell Mol Biol (2016) 0.81
Circulating biomarkers in pulmonary arterial hypertension: update and future direction. J Heart Lung Transplant (2014) 0.80
Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity. Front Pharmacol (2015) 0.80
Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats. PLoS One (2015) 0.80
CD4+ T cells and IFN-γ are required for the development of Pneumocystis-associated pulmonary hypertension. Am J Pathol (2013) 0.79
Steroid-sensitive gene 1 is a novel cyclic GMP-dependent protein kinase I substrate in vascular smooth muscle cells. J Biol Chem (2013) 0.78
E2F4 Promotes Neuronal Regeneration and Functional Recovery after Spinal Cord Injury in Zebrafish. Front Pharmacol (2016) 0.78
Reduction of plasma granzyme A correlates with severity of sepsis in burn patients. Burns (2010) 0.77
The Coiled-Coil Domain Containing 80 (ccdc80) gene regulates gadd45β2 expression in the developing somites of zebrafish as a new player of the hedgehog pathway. J Cell Physiol (2015) 0.76
The aging heart, endothelin-1 and the senescent cardiac fibroblast. J Mol Cell Cardiol (2015) 0.76
Thrombomodulin protects against lung damage created by high level of oxygen with large tidal volume mechanical ventilation in rats. J Intensive Care (2014) 0.76
Survival in an incident cohort of patients with pulmonary arterial hypertension in Denmark. Pulm Circ (2015) 0.76
Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons. PLoS One (2012) 0.76
Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy. Front Pharmacol (2016) 0.77